Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ADMA
#1705
ADMA Biologics Inc - Common Stock
7.9
8
USD
+0.63%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.63%
Monthly Change
-25.07%
6 month change
-57.91%
Year Change
-59.80%
Previous Close
7.9
3
Open
7.9
9
Low
7.9
7
High
8.0
4
Volume
1 398
Markets
US Stock Market
Healthcare
ADMA
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
121.28 M
195.92 M
222.16 M
228.22 M
237.62 M
238.16 M
231.77 M
Valuation ratios
Enterprise value
273.53 M
320.02 M
916.05 M
1.12 B
4.04 B
4.33 B
1.99 B
Price to earnings ratio
—
-2.76
-11.73
-35
21.17
30.4
12.25
Price to sales ratio
—
2.43
4.97
3.95
9.79
8.76
4
Price to cash flow ratio
—
-1.75
-12.87
115.81
35.17
88.64
15.79
Price to book ratio
—
1.39
5.04
7.54
11.96
9.36
1.2
Enterprise value to EBITDA ratio
-2.22
-5.97
-27.79
38.23
27.57
21.7
8.93
Profitability ratios
Return on assets %
-0.36
-0.26
-0.19
-0.09
0.4
0.24
0.07
Return on equity %
-0.86
-0.51
-0.43
-0.21
0.57
0.31
0.12
Return on invested capital %
-237.14
-139.79
-72.03
35.93
81.62
128.46
39.14
Gross margin %
-45.17
1.45
22.89
34.44
51.48
57.39
70.53
Operating margin %
-153.75
-72.12
-25.55
8.38
32.59
37.53
50.9
EBITDA margin %
-291.35
-66.19
-21.39
11.32
34.4
39.09
52.47
Net margin %
-179.41
-88.52
-42.77
-10.94
46.35
28.8
39.59
Liquidity ratios
Quick ratio
3.62
2.77
2.73
1.69
2.9
3.74
3.93
Current ratio
7.71
6.87
6.89
5.16
5.97
6.71
6.95
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.25
0.33
0.49
0.76
1.04
0.82
0.18
Solvency ratios
Debt to assets ratio
0.45
0.34
0.41
0.4
0.15
0.11
0.3
Debt to equity ratio
1.05
0.67
0.94
0.97
0.21
0.15
0.5
Long term debt to total assets ratio
0.03
-0.02
-0.03
-0.01
-0.01
0.12
0.3
Long term debt to total equity ratio
0.08
-0.04
-0.08
-0.03
-0.01
0.15
0.5
Per share metrics
Operating cash flow per share
—
-0.81
-0.3
0.04
0.49
0.21
0.53
EBIT per share
—
-0.42
-0.2
0.1
0.57
0.78
0.88
EBITDA per share
—
-0.38
-0.17
0.13
0.6
0.81
0.91
Total debt per share
—
0.68
0.72
0.58
0.3
0.28
0.82
Cash per share
—
0.37
0.44
0.23
0.42
0.36
0.58
Net current asset value per share
—
1.5
1.37
1.15
1.36
1.9
2.13
Tangible book value per share
—
1.01
0.77
0.6
1.43
1.93
1.61
Working capital per share
—
1.28
1.17
0.93
1.13
1.62
1.82
Book value per share
—
1.01
0.77
0.6
1.43
1.95
1.63
News
ADMA vs Intellia Therapeutics: Which Biotech Stock Is a Better Pick Now?
Can Asceniv Help ADMA Navigate the Current IG Market Challenges?
New Strong Sell Stocks for May 26th
Will the IG Market Challenges Affect ADMA Biologics Prospects in 2026?
Is it Time to Exit ADMA Biologics Stock After a 22% Monthly Plunge?
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?
New Strong Sell Stocks for May 14th
New Strong Sell Stocks for May 11th
ADMA Q1 EPS Jumps 73% Y/Y, Revenues Slip, 2026 View Down
Will the Label Expansion of Asceniv Boost ADMA's Top-Line Growth?
Adma Biologics (ADMA) Dips More Than Broader Market: What You Should Know
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet